Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GeneDx Holdings Corp. (WGS : NSDQ)

• Company Description    GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. Number of Employees: 1,300

• Price / Volume Information    Yesterday's Closing Price: $59.10 Daily Weekly Monthly 20 Day Moving Average: 638,438 shares Shares Outstanding: 29.69 (millions) Market Capitalization: $1,754.56 (millions) Beta: 1.90 52 Week High: $170.87 52 Week Low: $32.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.35% -16.02% 12 Week -9.61% -11.82% Year To Date -54.56% -58.03%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 333 Ludlow Street North Tower 6th Floor - Stamford,CT 06902 USA ph: 888-729-1206 fax: - investors@genedx.com http://www.genedx.com

• General Corporate Information    Officers Katherine Stueland - Chief Executive Officer and Director Jason Ryan - Chairman Kevin Feeley - Chief Financial Officer Eli D. Casdin - Director Emily Leproust - Director Peer Information GeneDx Holdings Corp. (CHCR) GeneDx Holdings Corp. (ESRX) GeneDx Holdings Corp. (MYDP) GeneDx Holdings Corp. (COR) GeneDx Holdings Corp. (GBCS) GeneDx Holdings Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 81663L200 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/03/26 Share - Related Items Shares Outstanding: 29.69 Most Recent Split Date: 5.00 (0.03:1) Beta: 1.90 Market Capitalization: $1,754.56 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.00 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 69.53 PEG Ratio: - Price Ratios Price/Book: 6.90 Price/Cash Flow: 25.78 Price / Sales: 3.96 EPS Growth vs. Year Ago Period: -200.00% vs. Previous Quarter: -300.00% Sales Growth vs. Year Ago Period: 17.38% vs. Previous Quarter: -15.48% ROE 06/30/26 - - 03/31/26 - 9.15 12/31/25 - 14.73 ROA 06/30/26 - - 03/31/26 - 5.21 12/31/25 - 8.67 Current Ratio 06/30/26 - - 03/31/26 - 3.09 12/31/25 - 2.46 Quick Ratio 06/30/26 - - 03/31/26 - 2.95 12/31/25 - 2.34 Operating Margin 06/30/26 - - 03/31/26 - 5.85 12/31/25 - 9.78 Net Margin 06/30/26 - - 03/31/26 - -17.58 12/31/25 - -4.92 Pre-Tax Margin 06/30/26 - - 03/31/26 - -17.50 12/31/25 - -4.94 Book Value 06/30/26 - - 03/31/26 - 8.57 12/31/25 - 10.54 Inventory Turnover 06/30/26 - - 03/31/26 - 11.07 12/31/25 - 10.54 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.38 12/31/25 - 0.16 Debt-to-Capital 06/30/26 - - 03/31/26 - 27.57 12/31/25 - 13.52

Powered by Zacks Investment Research ©